The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often viewed as outdated and hindering https://socialstrategie.com/story6456755/cannabinoid-rescheduling-a-growth-catalyst